Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study

Blood

Volumn 89, Issue 7, 1997, Pages 2488-2493

  Uckun, Fatih M ^a   Gaynon, Paul ^b   Sather, Harland ^b   Arthur, Diane ^b   Trigg, Michael ^b   Tubergen, David ^b   Nachman, James ^b   Steinherz, Peter ^b   Sensel, Martha G ^b   Reaman, Gregory R ^b  

^a University of Minnesota   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD2 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ANTIGENS, CD19; ANTIGENS, CD2; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, T-CELL; LIFE TABLES; MALE; PHENOTYPE; REMISSION INDUCTION; TREATMENT OUTCOME; TUMOR STEM CELLS;

EID: 0030970798     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Uckun FM: Regulation of human B-cell ontogeny. Blood 76:1908, 1990
2. Pui C-H, Behm FG, Crist WR: Clinical and biological relevance of immunological marker studies in childhood acute lymphoblastic leukemia. Blood 82:343, 1993
3. Greaves MF: Differentiation linked leukemogenesis in lymphocytes. Science 234:697, 1986
4. Champlin R, Gale RP: Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 73:2051, 1989
5. Uckun FM, Muraguchi A, Ledbetter JA, Kishimoto T, O'Brien RT, Roloff JS, Gajl-Peczalska K, Provisor A, Koller B: Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 73:1000, 1989
6. Lim SH, O'Conner S, Bloxham D, Lynn R, Broadbent V, Dyer MJS, Marcus RE: CD2+CD19+ Biphenotypic acute lymphoblastic leukaemia: A report of three cases and a review of the literature. Leuk Lymphoma 6:167, 1992
7. Lenormand B, Vannier JP, Bene MC, Falkenrodt A, Bayle C, Favre M, Garand R, Griveau AM, Briquet MT, Reman O, Boutard P, Tilly H, Faure G, Monconduit M, the Groupe D'Etude Immunologique Des Leucemics: CD2+CD19+ acute lymphoblastic leukemia in 16 children and adults: Clinical and biological features. Br J Haematol 83:580, 1993
8. Gaynon P, Steinherz P, Bleyer WA, Ablin A, Albo V, Finkelstein J, Grossman N, Littman P, Novak L, Pyesmany A, Reaman G, Sather H, Hammond D: Intensive therapy for children with acute lymphoblastic leukemia and unfavorable presenting features. Lancet 2:921, 1988
9. Steinherz P, Gaynon P, Miller D, Reaman G, Bleyer WA, Finkelstein J, Evans R, Meyers P, Steinherz L, Sather H, Hammond D: Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York Regimen - A new intensive therapy protocol. J Clin Oncol 4:744, 1986
10. Tubergen D, Gilchrist G, O'Brien R, Coccia P, Sather H, Waskerwitz M, Hammond D: Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features. J Clin Oncol 11:527, 1993
11. Steinherz PG, Siegel SE, Bleyer AW, Kersey J, Chard R Jr, Cocci P, Leiken S, Lukens J, Neerhout R, Nesbit M, Miller DR, Reaman G, Sather H, Hammond D: Lymphomatous presentation of childhood acute lymphoblastic leukemia. Cancer 68:751, 1991
12. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn E, Link M, Murphy S, Pui C-H, Pullen J, Reaman G, Sallon SE, Sather H, Shuster J, Simon R, Trigg M, Uckun F, Ungerleider R: A uniform approach to risk-classification and treatment assignment for children with acute lymphoblastic leukemia (ALL). J Clin Oncol 14:18, 1996
13. Uckun FM, Steinherz PG, Sather H, Trigg M, Arthur D, Tubergen D, Gaynon P, Reaman G: CD2 Antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: A Children's Cancer Group Study. Blood 88:4288, 1996
14. Uckun FM, Ledbetter JA: Immunobiologic differences between normal and leukemic human B-cell precursors. Proc Natl Acad Sci USA 885:8603, 1988
15. Hollander M, Wolfe D: Nonparametric Statistical Methods. New York, NY, Wiley, 1973
16. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
17. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
18. Peto R, Pike MC, Armitage P, Breslow N, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples. Br J Cancer 35:1, 1977
19. Cox DR: Regression models and life tables. J Royal Stat Soc B 34:187, 1972
20. Breslow N: Analysis of survival data under the proportional hazards model. Int Stat Rev 43:45, 1975
21. Uckun FM, Reaman G, Steinherz PG, Arthur D, Sather H, Trigg M, Tubergen D, Gaynon P: Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia: A Children's Cancer Group Study. Leuk Lymphoma 24:57, 1996
22. Hamdy N, Bhatia K, Shaker H, Kamel A, Nazli-Giad-El-Mawla MAE, El Sharkawy DYN, Magrath I: Molecular epidemiology of acute lymphoblastic leukemia in Egypt. Leukemia 9:194, 1995
23. Philip PJ, Monpoux F, Sudaka I, Baudouin F, Bayle J, Bene MC, Faure GC, the GEIL: Multiphenotypic Acute Leukemias: Clinicopathologic Correlations and Response to Therapy. Leuk Lymphoma 7:489, 1992